Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc.) on May 15, 2015. The report details material definitive agreements and the creation of direct financial obligations entered into by the registrant and its wholly-owned subsidiary, Apio, Inc.
Key Financial Metrics and Obligations
The filing discloses new financing commitments totaling approximately $37.4 million, structured as follows:
- Banc of America Leasing & Capital (BofA): A Master Loan and Security Agreement permitting Apio to borrow up to $15.0 million for equipment purchases made between October 1, 2014, and April 30, 2016.
- General Electric Capital Corporation (GECC): A commitment letter for two loans:
- Equipment Loan: Up to approximately $14.7 million for equipment purchases between May 1, 2015, and June 30, 2017.
- Real Property Loan: Approximately $7.7 million to finance facility expansion in Hanover, PA.
The filing does not provide current revenue, profit, cash flow, or margin data, as this is a current report regarding specific events rather than a periodic financial statement.
Material Changes and Loan Terms
The registrant has entered into new debt facilities and guarantees:
- BofA Loan Terms: Five-year term with a seven-year amortization. Interest is fixed based on the 2.5-year swap rate. Borrowings are secured by financed equipment. Landec Corporation has provided a guaranty for Apio's payment obligations.
- GECC Equipment Loan Terms: Five-year term with a seven-year amortization. Interest is fixed based on an index rate plus a 5-year swap rate (currently 2.98%). Secured by equipment and a registrant guaranty.
- GECC Real Property Loan Terms: Ten-year term with a 20-year amortization. Interest is fixed based on an index rate plus a 10-year swap rate (currently 4.19%). Secured by Apio's Hanover property and a registrant guaranty.
Outlook, Risks, and Contingencies
Management commentary indicates these facilities are intended to finance equipment purchases and facility expansion. The filing notes that interest rates for the GECC loans are subject to fluctuation before the loans are fully drawn. The registrant has assumed contingent liabilities by guaranteeing the payment obligations of its subsidiary, Apio, Inc., under both the BofA and GECC agreements.
Investor Verification Checklist
- Verify the exact interest rate calculations and swap rate indices referenced in the attached Proposal Letter and Commitment Letter.
- Confirm the specific covenants and default provisions within the Master Loan and Security Agreement (Exhibit 10.2) and GECC Loan Agreements.
- Assess the impact of the new debt obligations on the company's leverage ratios and liquidity position.
- Review the scope of the facility expansion in Hanover, PA, to understand the capital expenditure requirements.